Ceribell to Report Third Quarter 2024 Financial Results on November 12, 2024
Ceribell (Nasdaq: CBLL), a commercial-stage medical technology company focusing on neurological condition diagnosis and management, has scheduled its Q3 2024 financial results release for November 12, 2024, after market close. The company will host a conference call at 1:30 p.m. PT / 4:30 p.m. ET to discuss the results. Investors can join via phone using access code 7168007 or watch the webcast through Ceribell's investor relations website.
Ceribell (Nasdaq: CBLL), un'azienda di tecnologia medica in fase commerciale focalizzata sulla diagnosi e gestione delle condizioni neurologiche, ha programmato il rilascio dei suoi risultati finanziari del Q3 2024 per il 12 novembre 2024, dopo la chiusura del mercato. L'azienda ospiterà una conference call alle 13:30 PT / 16:30 ET per discutere i risultati. Gli investitori possono unirsi tramite telefono utilizzando il codice di accesso 7168007 oppure seguire il webcast attraverso il sito web delle relazioni con gli investitori di Ceribell.
Ceribell (Nasdaq: CBLL), una empresa de tecnología médica en etapa comercial centrada en el diagnóstico y gestión de condiciones neurológicas, ha programado la publicación de sus resultados financieros del Q3 2024 para el 12 de noviembre de 2024, después del cierre del mercado. La empresa llevará a cabo una conferencia telefónica a la 1:30 p.m. PT / 4:30 p.m. ET para discutir los resultados. Los inversores pueden unirse por teléfono utilizando el código de acceso 7168007 o ver la transmisión web a través del sitio web de relaciones con los inversores de Ceribell.
세리벨(Ceribell) (Nasdaq: CBLL)는 신경학적 상태의 진단 및 관리에 중점을 둔 상업용 의료 기술 회사로, 2024년 3분기 재무 결과를 2024년 11월 12일 시장 마감 후 발표할 예정입니다. 회사는 결과를 논의하기 위해 오후 1시 30분 PT / 오후 4시 30분 ET에 컨퍼런스 콜을 개최합니다. 투자자는 전화로 7168007 액세스 코드를 사용하여 참여하거나 세리벨의 투자자 관계 웹사이트를 통해 웹캐스트를 시청할 수 있습니다.
Ceribell (Nasdaq: CBLL), une entreprise de technologie médicale en phase commerciale axée sur le diagnostic et la gestion des troubles neurologiques, a prévu la publication de ses résultats financiers du T3 2024 pour le 12 novembre 2024, après la clôture du marché. L'entreprise organisera une conférence téléphonique à 13h30 PT / 16h30 ET pour discuter des résultats. Les investisseurs peuvent se joindre par téléphone en utilisant le code d'accès 7168007 ou suivre le webinaire via le site web des relations avec les investisseurs de Ceribell.
Ceribell (Nasdaq: CBLL), ein kommerzialisierungsfähiges Medizintechnikunternehmen, das sich auf die Diagnose und das Management neurologischer Erkrankungen konzentriert, hat die Veröffentlichung seiner Finanzergebnisse für das 3. Quartal 2024 für den 12. November 2024 nach Marktschluss geplant. Das Unternehmen wird um 13:30 Uhr PT / 16:30 Uhr ET eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen. Investoren können per Telefon unter Verwendung des Zugangscodes 7168007 teilnehmen oder die Webcast-Übertragung über die Website für Investor Relations von Ceribell verfolgen.
- None.
- None.
Investors interested in listening to the conference call may do so by dialing (800) 715-9871 for domestic callers or (646) 307-1963 for international callers and providing access code 7168007. A live and archived webcast of the event will be available in the "Investor Relations" section of the Ceribell website at https://investors.ceribell.com/.
About Ceribell Inc.
Ceribell is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Ceribell System is an AI-powered, rapidly deployable point-of-care electroencephalography ("EEG") platform designed to address the unmet needs of patients in the acute care setting. The company is headquartered in
Investor Contact
Brian Johnston or Laine Morgan
Gilmartin Group
Investors@ceribell.com
Media Contact
Corrie Rose
Press@ceribell.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/ceribell-to-report-third-quarter-2024-financial-results-on-november-12-2024-302290488.html
SOURCE Ceribell, Inc.
FAQ
When will Ceribell (CBLL) release Q3 2024 earnings?
How can I listen to Ceribell's (CBLL) Q3 2024 earnings call?
What time is Ceribell's (CBLL) Q3 2024 earnings call?
